Updated: Jan 11, 2008
The frontal lobe is the largest lobe in the brain, yet it is often not specifically evaluated in routine neurologic examinations. This may in part be due to the attention to detail and rigorous testing strategies required to probe frontal lobe functions. As successful completion of any cognitive task considered a frontal lobe function requires multiple brain regions both within and outside the frontal lobe, some authors prefer the term frontal systems disease. In any case, dysfunctions of the frontal lobe can give rise to relatively specific clinical syndromes. When a patient's history suggests frontal lobe dysfunction, detailed neurobehavioral evaluation is necessary.
Traditional classification systems divide the frontal lobes into the precentral cortex (the strip immediately anterior to the central or Sylvian fissure), prefrontal cortex (extending from the frontal poles to the precentral cortex and including the frontal operculum, dorsolateral, and superior mesial regions), and orbitofrontal cortex (including the orbitobasal or ventromedial and the inferior mesial regions). Each of these areas has widespread connectivity.
Given the unique connectivity between the frontal regions and deeper brain structures, lesions of these areas or their connections generate relatively distinctive clinical behaviors.
Broca aphasia from a lesion in areas 44 and 45 on the left hemisphere leads to nonfluent speech, agrammatism, paraphasias, anomia, and poor repetition. Lesions anterior, superior, and deep (but sparing) to the Broca area produce abnormal syntax and grammar but repetition and automatic language are preserved. This disorder is known as transcortical motor aphasia and uninhibited echolalia is common. Memory disturbances only develop with lesion extension into the septal nucleus of the basal forebrain. Appreciation of verbal humor is most impaired in right frontal polar pathology.
A detailed discussion of the pathophysiology of frontal lobe dysfunction is beyond the scope of this review and the reader is referred to 2 excellent reviews by Mesulam (2002) and Bonelli and Cummings (2007).1,2 As Mesulam has discussed, one way to think about the role of the frontal lobe is that it is the brain's way of modifying and interposing constraints on basic reflexive behaviors. For example, taking food when one is hungry is reflexive. Nonetheless, most adults can inhibit this behavior until the context is appropriate. Most hungry diners waiting in line at a restaurant do not usually help themselves to food from the plates of diners who have already been served, but some patients with frontal lobe dysfunction can't inhibit this response.
Unlike most animals, a human's mental state is preoccupied a great deal with what has happened in the past or what may happen in the future. Parts of the frontal lobe are essential for this type of "time travel." Indeed, good judgment requires evaluating the possible consequences of a variety of future activities and selecting the one with the most good consequences and the fewest bad consequences. Accordingly, poor judgment and inappropriately weighting the value of past experiences often occur with frontal lobe dysfunction.
Working memory involves a complex circuit that involves many brain regions, including the dorsolateral frontal cortex, thalamus, and parts of the temporal and parietal cortices. Working memory is defined as memory for a limited amount of information (such as a telephone number) that needs to be kept in consciousness for a few seconds (until the number is dialed) and then may be lost forever. Most patients are able to hold 6 or 7 digits in working memory. Patients with impairments of working memory may have decreased capacity in working memory (eg, shortened digit span) or difficulty manipulating information in working memory (eg, impaired reverse digit span test).
Data are not available for the epidemiology of frontal lobe dysfunction as a clinical syndrome, but data are available concerning the incidence and prevalence of the major causes of syndromes of frontal lobe dysfunction. For specifics on these data, please refer to the following linked eMedicine articles. Common causes (see also Causes) include the following:
Traumatic brain injury is much more common in men than women both in the United States and worldwide.
The relative likelihood of different causes of frontal lobe dysfunction is a function of patient age. In teenagers and young adults, the most common causes are mental retardation, traumatic brain injury, and drug intoxication. In middle-aged patients, brain tumors, cerebrovascular disease, infections such as HIV, multiple sclerosis, and early onset degenerative dementias are common. In late life, cerebrovascular disease and degenerative dementias are predominant causes of frontal lobe dysfunction.
The examiner must obtain a history from an informant who knows the patient well. One of the seeming paradoxes of frontal lobe dysfunction is that informants may complain about the patient's "inability to do anything," yet on at least cursory mental status testing, the patient appears normal or only mildly impaired. This dissociation should be a clue that frontal lobe dysfunction may be present. Symptoms of possible frontal lobe dysfunction that should be probed include change in performance at work and changes organizing and executing difficult tasks such as holiday dinners or travel itineraries. The examiner should inquire about the following changes:
In addition to these data, the examiner should obtain a careful developmental history, head trauma history, and social history, including educational and personal attainments. The examiner should also probe about possible substance abuse, whether the patient was a victim of past abuse (physical, sexual, psychiatric) and about major psychiatric stressor (eg, deaths of friends or family, divorce or separation, job loss or financial reversals). Indeed, a detailed past psychiatric history is required.
Dysfunction of parts of the frontal lobe is sometimes associated with aphasia or severe impairment of attention and can make formal neuropsychologic testing or neurobehavioral evaluation problematic.
Many commonly used brief mental state tests, including the Mini-Mental State Examination, are not designed to test frontal lobe function—they are insensitive and not specific to frontal lobe dysfunction. A person with a Mini-Mental State score of 26 from early Alzheimer disease may have relatively preserved frontal lobe function, yet a patient with Pick disease with a similar score may have profound frontal lobe dysfunction. Two recently validated bedside tools that extend the cognitive screen to the frontal lobes are the Frontal Assessment Battery (FAB)3 and the Montreal Cognitive Assessment (MoCA).4 These instruments may be helpful for bedside evaluation of frontal lobe function.
Most neurologists and psychiatrists are familiar with the general principles of evaluating frontal lobe function but a careful detailed evaluation usually requires consultation with a neuropsychologist or cognitive (behavioral) neurologist. Tests relatively sensitive to frontal lobe dysfunction include the following:
The manifestations of a frontal lobe syndrome in any patient depend on many factors, including baseline intelligence and education, site of the lesions, whether the lesions developed slowly or rapidly, age, possibly sex, and function of nonfrontal brain regions. Causes of frontal lobe dysfunction include mental retardation, cerebrovascular disease, head trauma, brain tumors, brain infections, neurodegenerative diseases including multiple sclerosis, and normal pressure hydrocephalus.
Cerebrovascular disease
The anterior cerebral artery supplies the medial surface of the brain, including the ventromedial frontal lobe, the cingulum, the premotor cortex, and the motor strip. Bilateral anterior cerebral artery infarct is associated with a syndrome of quadriparesis (legs worse than arms) and akinetic mutism.
Occlusion of the artery of Huebner may cause infarction of the head of the caudate nucleus and may result in an agitated confusional state that with time evolves to akinesia, abulia, and mutism, along with personality changes. Language may also be affected.
The anterior branches of the upper division of the middle cerebral artery supply parts of the lateral prefrontal cortex. Infarction of these arteries may be characterized by planning deficits, impairment of working memories, and apathy.
Borderzone infarctions between the distribution of the anterior and middle cerebral arteries are characterized by wedge-shaped lesions between the superior and middle frontal gyri and may result in the man-in-the-barrel syndrome with proximal weakness at the shoulder and hip.
Lacunar infarcts that occur in the deep white matter of the frontal lobe, caudate, or putamen may cause dysfunction of frontostriatal circuits.
Some patients with aneurysms and/or hemorrhage of the anterior communicating artery develop infarctions in the basal forebrain. In addition to the akinesia and personality changes already described, patients may develop a striking confabulatory amnesia that is severe and permanent and that resembles Wernicke-Korsakoff syndrome. Mild anomia may also be present.
Tumors
A classic presentation of frontal lobe dysfunction is an olfactory groove meningioma characterized by anosmia, loss of inhibition, memory impairment, headaches, and visual symptoms. The frontal lobes are also common sites for primary and metastatic brain tumors.
Traumatic lesions
Closed head injuries are often associated with unilateral or bilateral contusions of the orbitofrontal cortex. Some patients recover completely and others sustain lifelong impairments. The orbitofrontal cortex is susceptible to contrecoup injury when the accelerating brain strikes against bony prominences on the nonaccelerating surface of the anterior cranial fossa.
Prefrontal lobotomies or leukotomies were performed on some patients in the late 1940s and early 1950s with schizophrenia or other severe psychiatric illnesses. In these procedures, fibers connecting the frontal lobe with the basal ganglia were cut. Although some claimed that such patients performed normally on neuropsychological tests, studies were incomplete and lacking appropriate tests sensitive to frontal lobe dysfunction. Many patients performed normally on selected neuropsychological tests but were still unable to function independently.
Other structural causes of frontal lobe dysfunction
Hydrocephalus of any cause may be associated with frontal lobe dysfunction due to increased intracranial pressure and/or stretching of frontostriatal pathways. Normal pressure hydrocephalus (NPH) has received substantial attention as a reversible cause of dementia. Unfortunately, not all patients who seem to meet criteria for NPH are helped with surgery. Core features of NPH are gait apraxia, urinary incontinence, and frontal-predominant cognitive impairment.
Frontotemporal lobar degenerations (FTLD)
These disorders include at least 3 clinically distinguishable neurocognitive syndromes based on the location of the pathologic burden: (1) frontotemporal dementia (FTD), (2) primary progressive aphasia (PPA), and (3) semantic dementia (SD). These disorders are all slowly progressive neurodegenerative disorders.
Infectious causes of frontal lobe dysfunction
HIV frequently affects basal ganglia, hippocampus, and the deep white matter of the frontal lobe. The spectrum of cognitive impairment in HIV ranges from no impairment to HIV-dementia. Abscesses in the frontal lobe can also impair frontal lobe function.
| Alzheimer Disease | Cerebral Aneurysms |
| Alzheimer Disease in Individuals With Down
Syndrome | Glioblastoma Multiforme |
| Amyloid Angiopathy | Low-Grade Astrocytoma |
| Anterior Circulation Stroke | Meningioma |
| Aphasia | Pick Disease |
| Apraxia and Related Syndromes | Primary CNS Lymphoma |
| Arteriovenous Malformations | |
| Cardioembolic Stroke |
Dementia
Trauma
Alcoholism
Stroke
Substance abuse
Developmental disorder
Alexia
Neglect
Carotid disease and stroke
Medical care depends entirely on the pathology present.
Consultation with a neuropsychologist and/or behavioral neurologist is indicated to determine the nature and extent of the cognitive deficits present and to help work with the patients and families.
Formal consultation with a neuropsychologist is often advantageous to clarify the extent of the brain damage and to make appropriate cognitive treatment plans. Neuropsychologists are also exceedingly helpful because of their psychological background in dealing with patients and their families.
The patient and family frequently deny or minimize the importance of the deficit. Consultation can help ensure that the home setting is truly appropriate for the patient and/or family.
If a home setting is agreed on, these consultants can determine the need for assistance. Assistants can include physical, occupational, and/or speech therapists; home health aides; visiting nurses; respite care staff; and adult day-care staff, who are trained to help the patient succeed in the desired setting. Consultation with a social worker may also be helpful.
Patients with frontal lesions and deficits frequently need supervision because of their lack of impulse control and their inability to form and follow plans and strategies.
No medications are available to help frontal injuries.
Drugs that help memory in Alzheimer dementia are rarely of benefit for frontal lobe deficits or problems.
Outpatient care monitors what tasks a patient can accomplish in his home or residential facility and what tasks are a source of difficulty for the patient and his caregivers. Assessing how patients spends their time each day is useful.
The prognosis depends on the underlying pathology.
For patients in whom frontal lobe dysfunction is the result of strokes, visit eMedicine's Stroke Center. Also, see eMedicine's patient education article Stroke.
Mesulam MM. The Human Frontal Lobes: Transcending the Default Mode through Continent Encoding. In: DT Stuss and RT Knight. Principles of Frontal Lobe Function. Oxford: 2002:8-30.
Bonelli RM, Cummings JL. Frontal-subcortical circuitry and behavior. Dialogues Clin Neurosci. 2007;9(2):141-51. [Medline].
Dubois B, Slachevsky A, Litvan I, Pillon B. The FAB: a Frontal Assessment Battery at bedside. Neurology. Dec 12 2000;55(11):1621-6. [Medline].
Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. Apr 2005;53(4):695-9. [Medline].
Reitan RM. The relation of the trail making test to organic brain damage. J Consult Psychol. Oct 1955;19(5):393-4. [Medline].
Moll J, de Oliveira-Souza R, Moll FT, Bramati IE, Andreiuolo PA. The cerebral correlates of set-shifting: an fMRI study of the trail making test. Arq Neuropsiquiatr. Dec 2002;60(4):900-5. [Medline].
Pendleton MG, Heaton RK, Lehman RA, Hulihan D. Diagnostic utility of the Thurstone Word Fluency Test in neuropsychological evaluations. J Clin Neuropsychol. Dec 1982;4(4):307-17. [Medline].
Baker M, Mackenzie IR, Pickering-Brown SM, Gass J, Rademakers R, Lindholm C, et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature. Aug 24 2006;442(7105):916-9. [Medline].
Bech-Azeddine R, Hogh P, Juhler M, Gjerris F, Waldemar G. Idiopathic normal-pressure hydrocephalus: clinical comorbidity correlated with cerebral biopsy findings and outcome of cerebrospinal fluid shunting. J Neurol Neurosurg Psychiatry. Feb 2007;78(2):157-61. [Medline].
Benson DF, Miller BL. Frontal lobes, clinical and anatomic aspects. In: Feinberg TE, Farah MJ, eds. Behavioral Neurology and Neuropsychology. New York: McGraw Hill; 1997:401-8.
Cairns NJ, Bigio EH, Mackenzie IR, Neumann M, Lee VM, Hatanpaa KJ, et al. Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration. Acta Neuropathol (Berl). Jul 2007;114(1):5-22. [Medline].
Damasio AR. The frontal lobes. In: Heilman KM, Valenstein E, eds. Clinical Neuropsychology. 3rd ed. New York: Oxford Univerisity Press; 1993:409-60.
Lezak MD. Neuropsychological Assessment. 3rd ed. New York: Oxford; 1995.
Luria AR. The Working Brain. In: An Introduction to Neuropsychology. Haig B, trans. New York: Basic Books; 1973.
Marmarou A, Bergsneider M, Klinge P, Relkin N, Black PM. The value of supplemental prognostic tests for the preoperative assessment of idiopathic normal-pressure hydrocephalus. Neurosurgery. Sep 2005;57(3 Suppl):S17-28; discussion ii-v. [Medline].
Mesulam MM. Principles of Behavioral Neurology. 2nd ed. New York: Oxford; 2000.
Nagaratnam N, Bou-Haidar P, Leung H. Confused and disturbed behavior in the elderly following silent frontal lobe infarction. Am J Alzheimers Dis Other Demen. Nov-Dec 2003;18(6):333-9. [Medline].
Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. Oct 6 2006;314(5796):130-3. [Medline].
Nyatsanza S, Shetty T, Gregory C, Lough S, Dawson K, Hodges JR. A study of stereotypic behaviours in Alzheimer's disease and frontal and temporal variant frontotemporal dementia. J Neurol Neurosurg Psychiatry. Oct 2003;74(10):1398-402. [Medline].
Ondo WG, Chan LL, Levy JK. Vascular parkinsonism: clinical correlates predicting motor improvement after lumbar puncture. Mov Disord. Jan 2002;17(1):91-7. [Medline].
Stout JC, Wyman MF, Johnson SA, Peavy GM, Salmon DP. Frontal behavioral syndromes and functional status in probable Alzheimer disease. Am J Geriatr Psychiatry. Nov-Dec 2003;11(6):683-6. [Medline].
Vecera SP, Rizzo M. Spatial attention: normal processes and their breakdown. Neurol Clin. Aug 2003;21(3):575-607. [Medline].
frontal-lobe syndromes, mental status examinations, Mini-Mental State Examination, MMSE, Mental Status Examination, MSE, neuropsychology, precentral cortex, prefrontal cortex, orbitofrontal cortex, Alzheimer disease, amyloid angiopathy, anterior circulation stroke, aphasia, apraxia, arteriovenous malformations, cardioembolic stroke, carotid disease, cerebral aneurysms, glioblastoma multiforme, low-grade astrocytoma, meningioma, Pick disease, primary CNS lymphoma, echopraxia, antisaccade task
Thurstone test, semantic category fluency tasks, letter fluency task, design fluency, digit span, alternating sequences task, Luria's 3-step motor program, fist-palm-edge test, Paced Auditory Serial Addition Test, PASAT, Visual Span subtest of the Wechsler Memory Scale, Hamilton Depression Scale, Beck Depression Inventory, Zung Self-rating Depression Scale, Stroop test, classic Broca-type aphasia, National Institutes of Health Stroke Scale, NIHSS, deep dyslexia, Controlled Oral Word Association test, FAS test, Western Aphasia Battery test, WAB test, Boston Diagnostic Aphasia Examination, BDAE, Token testpraxis, buccofacial apraxia, callosal apraxia, anterior cerebral artery strokes, anosognosia, anosodiaphoria, neglect dyslexia, motor extinction, misoplegia, dressing apraxia, constructional apraxia, Wechsler Adult Intelligence Scale, WAIS, Rey Complex Figure Test, Wisconsin Card Sorting Test, WCST, Witzelsucht, factiousness, moria, pseudopsychopaths, frontosubcortical dementia, multiple sclerosis, AIDS, Parkinson disease, progressive supranuclear palsy, depressive pseudodementia, vitamin B-12 dementia, nutrition-related whole-brain atrophy, alcohol-related whole-brain atrophy, paratonic rigidity, vascular syndromes, middle cerebral artery strokes, artery of Huebner, akinesia, abulia, mutism, confabulatory amnesia, Wernicke-Korsakoff syndrome, anomia, agitated confusional state, frontal lobe tumors, gliomatous tumors, meningioma, subdural hematoma, prefrontal lobotomy, leukotomy, normal pressure hydrocephalus, gait apraxia, cortical atrophy, Boston naming test, frontotemporal dementias
Alberto J Espay, MD, MSc, Assistant Professor, Department of Neurology, University of Cincinnati
Alberto J Espay, MD, MSc is a member of the following medical societies: American Academy of Neurology and Movement Disorders Society
Disclosure: Boehringer-Ingelheim Consulting fee Consulting; Codman Grant/research funds Other; Medtronic Honoraria Speaking and teaching; Medtronic Grant/research funds Other; Allergan Grant/research funds Other; UCB-Schwarz Pharm Honoraria Speaking and teaching; Novartis Speaking and teaching
Daniel H Jacobs, MD, Associate Professor of Neurology, University of Central Florida College of Medicine
Daniel H Jacobs, MD is a member of the following medical societies: American Academy of Neurology, American Society of Neurorehabilitation, and Society for Neuroscience
Disclosure: Teva Pharmaceutical Grant/research funds Consulting; Biogen Idex Grant/research funds Independent contractor; Serono EMD Royalty Speaking and teaching; Pfizer Royalty Speaking and teaching; Berlex Royalty Speaking and teaching
Joseph Quinn, MD, Assistant Professor, Department of Neurology, Portland VA Medical Center, Oregon Health Sciences University
Joseph Quinn, MD is a member of the following medical societies: American Academy of Neurology, Society for Neuroscience, and Society for Pediatric Radiology
Disclosure: Nothing to disclose.
Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.
Richard J Caselli, MD, Professor, Department of Neurology, Mayo Medical School, Rochester, MN; Chair, Department of Neurology, Mayo Clinic of Scottsdale
Richard J Caselli, MD is a member of the following medical societies: American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, American Medical Association, American Neurological Association, and Sigma Xi
Disclosure: Nothing to disclose.
Matthew J Baker, MD, Consulting Staff, Collier Neurologic Specialists, Naples Community Hospital
Matthew J Baker, MD is a member of the following medical societies: American Academy of Neurology
Disclosure: Nothing to disclose.
Howard A Crystal, MD, Professor, Departments of Neurology and Pathology, State University of New York Downstate; Consulting Staff, Department of Neurology, University Hospital and Kings County Hospital Center
Howard A Crystal, MD is a member of the following medical societies: American Academy of Neurology and American Neurological Association
Disclosure: Pfizer Honoraria Speaking and teaching; Myriad Honoraria Consulting
© 1994-
by Medscape.
All Rights Reserved
(http://www.medscape.com/public/copyright)